[1] |
SUN Qiyue, ZHAO Ronghua, BAO Lei, GUO Shanshan, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing.
Safe doses of Lingyang Ganmao oral liquid for children based on the multi-animal model
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 121-126.
|
[2] |
ZHANG Jian, FANG Huihua.
Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
|
[3] |
LIU Wendong, CUI Huanhuan, WANG Xiaohan, SU Xian, WANG Haixue.
Status and thinking of Parmacovigilance regulatory system during clinical trials of the pediatric drug in China
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1002-1006.
|
[4] |
TAI Jun, YU Miao, ZHANG Lin, LEI Yi, LIU Junting, LI Tao, HUANG Guimin, CHENG Yijing, NIE Xiaolu, WANG Qing.
Active monitoring of adverse reactions related to haemocoagulase agkistrodon for injection in children
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1011-1016.
|
[5] |
YANG Le, XIA Dongsheng, WANG Tao.
Risks to safety of vitamin B6 injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 791-794.
|
[6] |
WANG Ran, FENG Xin, DU Boran.
Advances in risk assessment and pharmaceutical care of pregnancy medication exposure during perinatal period
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 836-840.
|
[7] |
.
Annual report of national adverse drug reaction monitoring (2022)
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 712-719.
|
[8] |
ZHANG Qingxia, ZHOU Liujun, LI Xiaoling, WANG Yuqin.
Cefoperazone/sulbactam-related medication errors in the elderly and countermeasures
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 574-578.
|
[9] |
ZHANG Zhiqi, GUO Mingxing, XU Ye, ZHANG Jian, LIN Jun, CUI Xiangli.
One case of tacrolimus-caused reversible posterior leukoencephalopathy syndrome after renal transplantation in children
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 465-468.
|
[10] |
JIA Zhaoguang, XU Wenshuai, JI Li’na, WANG Linlin, ZHAO Li’na, ZHAO Jingquan, MU Xiangdong.
Diagnosis and treatment of mycoplasma pneumoniae pneumonia in children and rational administration of related drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1391-1395.
|
[11] |
LEI Chao, QIAO Meng, CHEN Zijia, ZHANG Qiang, XIE Yanming, WANG Zhifei.
Revision of safety information in instructions of traditional Chinese patent medicines and simple preparations
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1396-1400.
|
[12] |
QIAO Meng, LEI Chao, CHEN Zijia, ZHANG Qiang, WANG Zhifei.
Analysis and thinking on the status quo of safety item information in the instructions of traditional Chinese patent medicines containing Asari Radix et Rhizoma and its extracts
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1401-1406.
|
[13] |
YANG Le, XIA Dongsheng, WANG Tao.
Risks to safety of vitamin B2 injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1256-1258.
|
[14] |
PENG Jing, TUO Yali, LI Qiaoling, ZHOU Rong, LI Xinlin, PENG Hui.
Data analysis of adverse events of clobazam among children based on foreign pharmacovigilance safety spontaneous reporting system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1264-1268.
|
[15] |
CAO Xiaoyu, WANG Ying, WANG Jingwen, YANG Ruixia, GE Jie.
Analysis of agranulocytosis in a child induced by vancomycin injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 106-109.
|